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Abstract  
 
With the aim of developing new drug carriers for inhalation therapy, we report here an in depth investigation 
of the structure of multilamellar liposomes loaded with two well-established anti-tubercular (anti-TB) drugs, 
isoniazid (INH) and rifampicin (RIF), by means of small-angle neutron-scattering (SANS) analysis. 
Unloaded, single drug-loaded and co-loaded liposomes were prepared using different amounts of drugs and 
characterized regarding size, encapsulation efficiency and drug release. Detailed information on relevant 
properties of the investigated host-guest structures, namely the steric bilayer thickness, particle dispersion, 
number of lamellae and drug localization was studied by SANS. Results showed that RIF-liposomes were 
less ordered than unloaded liposomes. INH induced a change in the inter-bilayer periodical spacing, while 
RIF-INH co-loading stabilized the multilamellar liposome architecture, as confirmed by the increment of the 
drug loading capacity. These findings could be useful for the understanding of in vitro and in vivo behavior 
of these systems and for the design of new drug carriers, intended for inhaled therapy. 
 
 
KEYWORDS: multilamellar liposomes; drugs-lamellae interactions; small-angle neutron scattering; 
isoniazid; rifampicin. 
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1. Introduction 
Tuberculosis (TB) is one of the world’s deadliest communicable diseases [1]. Since Mycobacterium 
tuberculosis (Mtb) tends to localize in the lungs, the administration of therapeutic agents through the 
pulmonary route could be a valid strategy to improve the efficacy of drugs, as it allows the deposition of the 
active pharmaceutical ingredient (API) directly at the infection site, avoiding first-pass metabolism and 
reducing systemic side effects. Recently, liposomes have been proposed as new drug delivery carriers for 
inhalation therapy, to improve drug targeting and delivery [2,3]. The success of targeting alveolar 
macrophages depends critically on the chemico-physical characteristics of the nanocarriers, namely their 
size, shape, density, porosity, surface charge and presence of specific molecules involved in the receptor-
mediated endocytosis [2,4]. Rifampicin (RIF) and isoniazid (INH), two powerful first-line anti-TB drugs 
provided with a very different water solubility (INH LogP -0.64 and RIF LogP 3.719) [5,6], were here 
chosen as drug models for co-loading experiments, using conventional liposomes prepared with 
phosphatidylcholine (PC) and cholesterol (Chol). Considering the liposomal architecture, both the 
hydrophilic INH and the hydrophobic RIF were encapsulated within the nanoparticle, as they could interact 
with its different components, namely the lipid bilayers (RIF) and the central aqueous core (INH) [7]. 
Therefore, it was conceivable that these drugs could be located inside the liposomal formulations, as 
depicted in the model shown in Figure 1. 
Taking into account that the co-administration of RIF and INH (Rifinah®) improves the outcomes in TB 
patients, we co-loaded these two drugs in the same formulation for pulmonary delivery. Following this 
approach, these nanocarriers may acquire better pharmacokinetic properties, thus ensuring greater efficacy 
[8]. This strategy could also be conveniently applied for the administration of non-traditional antitubercular 
agents, targeting new druggable molecular pathways [9–11], with the aim of tackling the growing incidence 
of drug resistant infections [12]. In addition, the formulation of carriers, shipping high amounts of drugs, 
generally improves patient compliance and reduces systemic adverse effects. 
In order to fully address these issues, an in-depth characterization of the nanocarriers is of critical 
importance for optimizing the loading conditions. Among the available techniques, small-angle neutron 
scattering (SANS) has recently emerged as a powerful tool to investigate amphiphilic aggregates, such as 
uni-lamellar and multi-lamellar vesicles [13]. In particular, SANS provides crucial information about the 
arrangement and behavior of the drug into the nanoparticle after its encapsulation and allows the analysis of 
these systems at nanometric level. This technique yields valuable and unique data about steric bilayer 
thickness, particle dispersion and the finer structural features. In detail, it is possible to determine: the core 
radius (rc), the shell thickness (ts), the shell scattering length density (SLD, ρs), the water layer thickness 
(tw), the water scattering length density (SLD, ρ0), the number of layers (N) and the overall liposome size 
(see Figure 2) [14]. 
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Therefore, we decided to apply this technique on liposomes co-loaded with RIF and INH, comparing this 
formulation with mono-loaded liposomes, in order to deeply characterize the structure of the carrier and any 
perturbation induced by the presence of these drugs, under physiological conditions and without any earlier 
manipulation [15]. We complemented this SANS study with Photon Correlation Spectroscopy (PCS) 
analysis and drug release studies, in order to obtain key information on our new host-guest structures, for a 
synergistic and site-specific antitubercular therapy. 
 
 
 
2. Materials and Methods 
2.1 Materials 
Cholesterol (Chol, ≥99%) was purchased from Sigma Aldrich (St. Luis, MO, USA), phosphatidylcholine 
(PC, 95%) from Egg yolk was obtained by Fluka Chemie (Buchs, Switzerland). Rifampicin (RIF, Lot. No 
17447/BR, purity calculated according current Ph. Eur.: 97-102%) was a kind gift from Sanofi (Brindisi, 
Italy), while Isoniazid (Isonicotinic Acid Hydrazide, INH, 98.0%) was purchased from T.C.I Europe 
(Zwijndrecht, Belgium). Finally, deuterium oxide (D2O, Lot. 170009, 99.96%) was purchased from VWR 
(Milan, Italy). All solvents employed were of analytical grade.  
2.2 Liposome preparation 
Liposomes were prepared using the Reverse Phase Evaporation (REV) technique and homogenized using an 
Ultraturrax device (Ika-euroturrax T 25 basic, IkaLabortechnik, Staufen, Germany) [16]. 
Cholesterol (Chol) and phosphatidylcholine (PC) with fixed molar ratio (1:1) were weighed and solubilized 
in chloroform at the final concentration of 40 mM. The obtained solution was placed into a glass flask, and 
the solvent was removed under vacuum at room temperature until the formation of a dry film (Buchi HB-
140, Buchi, Swiss). The phospholipid film was re-dissolved in diethyl ether and mixed with water (3:1 
ratio). This suspension was vortexed to form a W/O emulsion; than the emulsion was stirred for 2 hours at 
200 rpm to remove the organic solvent, inducing the phase reversal and, finally, the formation of liposomes 
(MLV). Liposomes were homogenized by Ultraturrax (Ika-euroturrax T 25 basic, IkaLabortechnik, Staufen, 
Germany) for 3 minutes and purified by dialysis for 30 minutes in order to separate the free drugs before 
being stored at +4 °C in vials. For loaded liposomes, RIF:lipid (w/w) ratios of 3:100, 6:100, 12:100 (for RIF 
3%, 6%, 12% samples, respectively) were used, adding the drug to the chloroform solution along with the 
lipids; for INH-loaded liposomes 15:100, 30:100, 60:100 drug:lipid (w/w) ratios were employed (for INH 
15%, 30%, 60% samples, respectively), adding INH to the water phase mixed with diethyl ether. For the 
preparation of liposomes encapsulating INH and RIF (Co-loaded liposomes), a RIF:INH:lipid (w/w) ratio of 
12:15:100 was employed.  
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For SANS analysis, liposomes were prepared and purified using D2O instead of milliQ water. 
 
 
 
2.3 Photon Correlation Spectroscopy (PCS) 
Liposome size and polydispersity index (PDI) were determined by photon correlation spectroscopy (PCS) 
technique using a Zetasizer Nano ZS analyzer system (Zetasizer version 6.12; Malvern Instruments, Worcs, 
U.K.). The results were expressed as the average of three different measurements. 
Analysis was performed in triplicate and each measurement was averaged over at least 12 runs. 
 
2.4 Drug loading and Encapsulation Efficiency 
The drug loading (DL %) and the encapsulation efficiency (EE %) of loaded-liposomes were evaluated by 
UV-visible spectroscopy (Lambda 3B Perkin-Elmer, Wotham, USA). For the determination of the 
hydrophilic drug (INH), 300 µL of liposomal suspension was dissolved in 1.5 mL of isopropanol and this 
solution was diluted with MilliQ water. The amount of incorporated INH was determined in the solution by 
recording the absorbance at λ = 262 nm. In the same way, for the determination of RIF, 300 µL of liposomal 
suspension was dissolved in 1.5 mL of isopropanol and this solution was diluted with methanol. The amount 
of incorporated RIF was determined by recording the absorbance at λ = 475 nm. 
The absorbance of the solutions containing the drugs was converted to the amount of drug by preparing 
standard calibration curves constructed using supernatants of the corresponding unloaded liposomes (n = 6), 
in order to eliminate any possible interference in the measurements. 
The direct quantification of drug amounts in co-loaded liposomes using UV-visible spectroscopy cannot be 
performed, since INH absorption spectrum is overlapped to that of RIF [17]. For this reason, to determine 
INH peak-to-peak first-order derivative, UV spectroscopy was employed. Gürsoy et al. demonstrated the 
reliability of derivative UV spectrophotometry for the simultaneous estimation of RIF and INH, avoiding the 
interference problem related to spectral overlap at 262 nm [18]. 
DL % and EE % were calculated with the following equations:  
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The method to determine the amount of RIF and INH in liposomes has been validated by using 
unloaded liposomes spiked with known quantities of drugs. 
 
 
 
2.5 Drug release studies 
The in vitro release of RIF and INH from liposomes was analyzed in Simulated Lung Fluid (SLF) at pH 7.4 
[19]. Briefly, 1 mL of liposome suspension placed in a semipermeable membrane (Dialysis Tubing - 
Visking MWCO-12-14000 Daltons, Medicell International Ltd, London) was immersed into a vessel 
containing 30 mL of SLF medium and maintained at 37 ± 0.5 °C under gentle stirring. At fixed time 
intervals, aliquots (1 ml) were withdrawn from the solution and INH and/or RIF content was determined by 
spectrophotometry, as previously described (Lambda 35). Two aliquots were analyzed for each time point 
using unloaded liposomes as blank and the study was performed in triplicate. 
 
2.6 SANS experiment 
Nanoparticles characterization was undertaken using the fixed-geometry, time-of-flight small angle neutron 
scattering Sans2d instrument at the ISIS Spallation source at the Rutherford Appleton Laboratory, U.K. 
A scattering vector q = (4π/λ) sin(θ) (where λ is the neutron wavelength and 2θ is the scattering angle) range 
between 0.001 and 0.5 Å
−1
 was obtained by using neutron wavelengths spanning from 2.2 to 10 Å, with a 
sample–detector distance of 4 and 12 m. 
The samples were contained in 2 mm path length, UV-spectrophotometer grade, quartz cuvettes and 
mounted on aluminum holders on top of an enclosed, computer-controlled, sample chamber. Temperature 
control was achieved by using a thermostated circulating bath pumping fluid through the base of the sample 
chamber, achieving a temperature stability of ± 0.2 °C. The experiments were run at 25 °C using 0.6 mL 
volume samples in quartz cuvettes (Hellma, GmbH). To maintain the degree of purity of D2O and avoid 
phenomena of deuterium chemical exchange, the SANS measurements were performed in controlled 
hermetic conditions. 
All scattering data were (a) normalized for the sample transmission, (b) background corrected using a quartz 
cell filled with the solvent used (D2O), and (c) corrected for the linearity and efficiency of the detector 
response (component of the instrumental smearing) using the instrument specific software package [20]. The 
experimental time of a single measurement was between 30 and 60 minutes. 
The experimental data were analyzed using the multi-shell spherical model of the fitting routine SASView 
2.2.0, in the context of a spherical core-shell morphology.  
SANS experiments were carried out to quantify the specific type of aggregated system (observed by the 
previous techniques), in terms of shape and size characteristics. The scattering intensity detected by this 
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technique contains intra-particle information (size, shape) and inter-particle information (interactions 
between the scattering centers of the aggregated systems) in solution (eqn (1)), 
I(q) = NpVp
2Δρ2P(q)S(q) + B  (1) 
where Np is the number of scattering particles per unit volume, Vp is the volume of one scattering particle, 
Δρ is the difference in scattering length density (SLD) in the system (known as contrast), P(q) is the form 
factor and gives intra-particle information (size and shape), S(q) is the structure factor and gives inter-
particle information (particle interactions), B is the background signal. 
According to the employed model [21], the scattering intensity of non-interacting (S(q) ~ 1) multilamellar 
vesicles is given by the formula: 
      
 
     
       
        
                     
      
       
                     
      
 
   
 
 
       
where   is the volume fraction of the particles in solution,    is the total radius of the multilamellar 
liposome containing   layers,      is the volume of a sphere with radius  ,    is the shell SLD,    is the 
solvent SLD, ,                    with    water core radius and    and    thickness of the lipid layer 
and of the solvent, respectively;         . The size     of the multilamellar vesicles is calculated from 
the values of the parameters extrapolated from the best fits of the SANS curves according to the formula 
                       . 
In the fitting procedure and data analysis, the following foresights have been employed: (a) a polydispersity 
(PDI) following a Gaussian distribution has been considered for the structural parameters   ,    and   ; (b) 
the SLD values 0 and s (with default scale was 1 and background 0.02 cm
-1
) were initialized according to 
literature [22] and optimized in the fitting procedure in order to evaluate SLD changes attributable to the 
presence of the drugs, both in the water and in the lipid layers; (c) the fit quality was determined by the 
reduced χ2 value, which is reported in the caption of the corresponding Figures. Neither aggregation 
processes nor appearance of precipitate were revealed by visual inpection. In this respect, the SANS 
measurement was repeated twice to ensure that the system was effectively at equilibrium. 
Due to the huge difference in the coherent scattering lengths of deuterium and hydrogen, the D2O/H2O 
contrast variation SANS methodology allows a well distinguished scattering from the shell with respect to 
the corresponding inner content. Therefore, by using D2O in the external phase of the liposomal system, we 
gained information on the morphology and structure of the lipid shell correlated to the loaded drug 
placement. 
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2.7 Statistical analysis 
Statistical analysis was performed using the one-way analysis of variance (ANOVA). The data are 
represented as means ± SD. Differences were considered statistically significant at p-values less than 0.05 
(*p<0.05; **p<0.01; ***p<0.005). 
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3. Results 
3.1 Liposome characterization 
Data of size, polydispersity index (PDI), determined by PCS analysis, encapsulation efficiency and drug 
loading of the analysed liposomes are shown in Table 1. 
No significant size differences could be appreciated between the drug-loaded liposomes and the 
unloaded samples. With respect to particle size distribution, the polydispersity index (PDI), used to define 
the degree of homogeneity of a size distribution of particles, is a parameter given by the Zeta sizer analyzer 
System. Generally, a PDI of 0.3 and below is considered to be acceptable for drug delivery systems and 
indicates a monomodal distribution of vesicles [23]. Regarding this value, we observed that if we increased 
the amount of RIF from 3 mg to 12 mg, a PDI increment from 0.283 to 0.440 followed. With respect to 
INH-loaded liposomes, differences neither in size nor in PDI values could be appreciated in the differently 
concentrated drug-loaded samples. Finally, the co-loaded sample presented the same size and intermediate 
PDI value as compared to the homologous single loaded samples. 
Concerning encapsulation efficiency, UV-vis spectroscopy analysis indicated that about 50% of both 
the drugs were incorporated in each sample, regardless of the drug/lipid ratio adopted. As for the drug 
loading capacity, this parameter increased proportionally with the initial amount of added drug. The co-
loading of RIF and INH in the liposomes significantly increased the encapsulation efficiency, with respect to 
the formulations containing the equivalent amount of the single drug. 
 
3.2 Release studies 
 
As shown in Figure 3, single loaded RIF and INH liposomes showed no significant differences in the drug 
release profile, independently to the amount of drug loaded. In agreement with its hydrophilic features, INH 
release rate was faster than that of RIF: 80-90% of INH was released in 5 hours, whereas 25-35% of RIF 
was released in the same time frame. As for the co-loaded liposomes, each drug showed the same release 
rate of the homologous single-loaded liposomes. 
 
3.3 SANS experiment 
The SANS data are displayed in Figures 4-6, as absolute scattering intensity (shifted vertically) plotted as a 
function of the scattering vector q. Error bars correspond to one standard deviation of the mean scattering 
intensity. Figures 4-6 reports the superimposed SANS profiles of representative samples of liposomes 
loaded with different concentrations of RIF, INH and both drugs respectively, together with the 
corresponding best fit performed by SasView by using the well-established multi-lamellar vesicle model 
[19]. This model provides the form factor, P(q), for a multi-lamellar vesicle depicted in Figure 2 with N 
lipid-drug shells of a span ts and a scattering length density s, where the core is filled with solvent and the 
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shells are interleaved with solvent-drug layers of a span tw and a scattering length density 0. All the 
parameters extrapolated from the best fits are reported in Tables 2 and 3. 
Unloaded liposomes assemble in solution as oligo-lamellar vesicles constituted of roughly 6 concentric 
bilayers giving rise to a periodicity of ~ 68 Å (shell + water thickness), compatible with the thickness of 
each bilayer [24]. The vesicles are stable and show a spherical shape, well-matched with the best fit model 
used, with a size of ~ 420 nm (Table 2). 
Regarding RIF-loaded liposomes, a reduction in the shell scattering length density (SLD, s) with respect to 
the unloaded liposomes was observed. This effect is symptomatic of structural modifications of the lipid 
bilayers due to a different packing of the lipid molecules upon the inclusion of the hydrophobic drug. On the 
contrary, no significant perturbations were appreciated in SLD of deuterated water confined among the 
shells and in the core of liposomes.  
Such RIF hydrophobic interaction modifies the structure of the multi-lamellar arrangement, in proportion to 
the concentration of the drug in the lipid (from 3% to 12%) (Figure 4). In particular, starting from RIF at 6% 
concentration, we detected a reduction of the lamellae number with a concomitant slight increase in the 
periodical spacing, given by the repetition of the liposome lipid bilayers, and polydispersity of the shell 
thickness, obtained comparing the best fit parameter values, which changes to 0.5 and 0.6 for RIF at 6% and 
12% respectively, compared to 0.3 obtained for the lowest RIF concentration. In addition, no significant 
aggregation was detected. The best fit results are reported in Table 2. 
Regarding INH-loaded liposomes, the hydrophilic drug does not seem to induce significant changes in the 
multi-lamellar assembly of unloaded liposomes (Figure 5). In fact, our results indicate that the lamellae 
number of oligo-lamellar vesicles is maintained up to 60% of INH (Table 2). At the highest tested 
concentration, the drug embedded within the liposomes induced a slight but significant decrease in the 
water-drug phase SLD, 0 of the system, with a change in the inter-bilayer periodical spacing and a slight 
change in size of the liposomes. 
Finally, the effect of the co-loading of both drugs on the liposomes was examined. Taking into account the 
structural modification which can affect the liposome stability due to the presence of the drugs, the 
combination of RIF at 12% and INH at 15% was chosen. In co-loaded liposomes the structure of the multi-
lamellar arrangement was not affected by the presence of RIF. This is in contrast with the results obtained 
for RIF-loaded liposomes, despite the same amount of RIF was used in the formulation. The SANS data 
depicted in Table 3 indicated the presence of the drugs both in the water compartments and in the bilayer. 
Moreover, the vesicle demonstrated to be stable with a spherical shape, as evidenced from the goodness of 
the best fit with a multi-shell spherical model. 
In order to better visualize the obtained results, the SLD profiles have been reconstructed from the values of 
the structural parameters, extrapolated from the best fits, as a function of the liposome radius. The profiles 
obtained for the liposomes loaded with the highest drug concentrations (RIF 12% and INH 60%) and 
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liposomes co-loaded with both the drugs (RIF 12% and INH 15%) are reported in Figure S1, in comparison 
with the unloaded sample. 
 
4. Discussion 
Liposomes here described, co-incorporating RIF and INH, are intended for inhaled chemotherapy against 
pulmonary TB; they were designed to reach a higher antimycobacterial potency and improve the drug 
therapeutic profile [25]. The addition of two different drugs inside liposomal vesicles could alter the carrier 
structure; therefore, we performed an in-depth structural study in order to investigate any possible 
destabilization of the liposome framework. 
PCS analyses on the liposome samples showed no differences in size, regardless of the type and amount of 
the embedded drug. All the samples have an average diameter around 350 nm, demonstrating the suitability 
to be analyzed by SANS (Table 1) [14]. Regarding the PDI value, we observed some differences among the 
analyzed samples. For RIF-loaded liposomes, a parallel increase in the PDI values with the drug loading was 
detected, suggesting a drop of size homogeneity when an increase of drug loading occurred. This effect 
might be due to changes in the structural organization of the lipid bilayer caused by the hydrophobic drug, 
which may interact with phospholipid tails of the liposome lamellae [26,27]. In INH-loaded liposomes, the 
size homogeneity did not change with the increase of the drug loading, probably because INH is highly 
soluble in water and its interaction with the phospholipid lamellae is low. Finally, PCS analysis of co-loaded 
liposomes showed an intermediate value of PDI, with respect to the loaded and unloaded samples, indicating 
the opposite influence of the two drugs on the homogeneity of the vesicle size. 
The results of PCS analysis were further supported by SANS data. By fitting the scattering curves, a 
destabilization of liposomal structure of RIF-loaded liposomes was highlighted. The fit parameters showed 
that the size underwent a slight decrease (too small to be detected by PCS analysis) with respect to the 
unloaded carrier. This modification is probably due to interactions between the hydrophobic tails of 
phospholipids and RIF. Moreover, at higher concentrations, the Bragg peak, indicating the spacing of the 
planes satisfying the Bragg’s law, was wider and the lamellar structure appeared destabilized. The behavior 
in the presence of the hydrophilic drug INH was different, since liposome dimension and multi-lamellar 
assembly did not significantly change up to 60% of INH. The hydrophilicity of this drug leads to its 
confinement in the aqueous environment of the core and in the inter-bilayer spaces composing the liposome 
shell. Relevant changes in the stereochemistry of the multilamellar vesicles and, in particular, in the 
thickness of the water and lipid layers tw and ts are not observed at the lower INH concentrations (15% and 
30%). In contrast, for the sample with the highest INH concentration, a slight but significant decrease in 
both ts and tw is detectable, along with a decrease in the number of lamellae and a lower measured size (~ 
403 nm). The position of INH within the liposome is also confirmed by water-drug layer SLD 0, whose 
value decreases with the drug concentration respect to that of pure D2O. Moreover, the change in the inter-
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bilayer periodical spacing suggests the formation of interactions between the drug and the phospholipid 
heads, at the water-lipid interface. These interactions are probably hydrogen bonds or van der Waals forces, 
giving rise to slight changes in the liposome size, which cannot be detected by PCS analysis. In more detail, 
the interaction of the phosphate region of the phosphatidylcholine’s polar heads with the INH molecules 
could enhance the choline motional freedom [28], affecting the packing of the lipid bilayer. This effect is 
coherent with the observed decrease of the lipid bilayer thickness, which shifts from 5.0 nm for the unloaded 
samples to 4.8/4.6 nm for the INH-loaded vesicles. Notably, the disorganization of the lipids within the 
bilayer leads to an increment of the membrane fluidity, promoting the penetration of water molecules [29] 
and thus resulting in a slight increase of the shell SLD s for all the INH-loaded samples with respect to that 
of the control. 
As confirmed by PCS studies, the SANS profiles for the co-loaded liposomes highlighted that, in the 
experimental condition adopted, it is possible to obtain stable liposomes co-embedded with both drugs. 
Notably, SANS data suggested that the hydrophobic RIF determines a large destabilization of the multi-
lamellar vesicular structure, while the co-presence of INH and RIF causes an intriguing stabilization effect 
on the oligo-lamellar shelled liposome (Table 3). This synergistic effect promoted the uptake of both drugs 
inside the vesicles, as confirmed by the drug loading results. Taking into account the previous outcomes, it is 
important to underline that co-loaded liposomes proved to be able to incorporate higher amount of both 
drugs, even if the loading capacity was high for INH but not for RIF. This effect was previously observed in 
other studies and it was attributed to the enhanced solubility of RIF and INH in mixture [18]. On the basis of 
the results of SANS analysis, it is possible to provide a more detailed description for this phenomenon. The 
increased amount of RIF loaded might be explained by the structure stabilization exerted by the co-presence 
of INH, while the higher INH loading could be attributable to an increase in the lipid bilayer rigidity, 
induced by the intercalation of the hydrophobic RIF, during liposome formation. To the best of our 
knowledge, SANS data corroborate information provided by other spectroscopic techniques reported in the 
literature [26,27]. 
With regard to drug release, this effect did not elicit any significant variation in the in vitro behavior of these 
systems. Despite the different localization of the two drugs within the nanocarriers, the presence of RIF and 
IHN in the same liposome did not modify the release profiles of each drug, which remained substantially 
unaltered with respect to those of the mono-loaded formulations. A similar result was obtained by Gürsoy et 
al. [18], who used liposomes constituted of natural phosphatidylcholine, which possessed a low transition 
temperature, resulting in high membrane fluidity [30]. 
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Conclusions 
In this paper, we studied several liposome formulations as carriers for the most used anti TB-drugs: RIF and 
INH. Our data demonstrated the importance of SANS in defining not only the drug localization (expected 
data), but also the role that the drugs play in contributing to the stability of single and co-loaded liposomes. 
Studies performed with liposomal forms of tuberculostatics showed that the bilayer composition is critical 
for targeting liposomes and for obtaining stable drug-liposome formulations [31]. Moreover, a 
comprehensive study explaining the complex interaction between these drugs and liposomes is still lacking.  
We showed that the SANS technique is able to define RIF and INH localization within MLV liposomes and 
drug-lipids interactions, providing important clues for obtaining stable nanoparticles to be used in 
tuberculosis therapy. In particular, we calculated the size of MLV and we obtained detailed information on 
their fine structure. Moreover, we described the changes, both in the water and in the lipid layers, 
attributable to the presence of the drugs, as these latter interfered with the MLV self-assembling. In the case 
of RIF-loaded liposomes, the hydrophobic molecules, embedded in the lipid bilayers, altered the lipid 
organization in the lamellae; we highlighted that this effect depends on the RIF concentration. Regarding the 
interaction of the hydrophilic INH with the phospholipid heads at the water-lipid interfaces, we evidenced 
that INH affected the bilayer structure as well as the organization of the coordinated water, in the water 
leaflet between the lamellae. The penetration of water molecules in the bilayer increased the distances 
between lipid molecules, producing in this way a sort of “membrane fluidification effect”. When RIF and 
INH are co-loaded, the SANS data demonstrated that a sort of stabilization of the structure and dimension of 
the liposome occurred, which might promote, in a synergistic way, the embedding of both drugs. 
In conclusion, SANS analysis supplies much more detail about the size than PCS and provides in depth 
information about the architecture of liposomes, allowing to better understand the effects and the 
localization of these drugs inside the liposomes. In addition, the stabilization effect on the structure and 
dimensions of the liposome when RIF and INH are co-administered is an encouraging result for the 
development of more efficient nanoparticles. 
All these outcomes represent the key preliminary step for the understanding of the in vitro and in vivo 
behavior of these systems and for the designing of new drug carriers, intended for inhalation therapy.  
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Table 1. Particle size (nm), polydispersity index (PDI), Encapsulation Efficiency (EE %) and Drug Loading 
(DL %) of unloaded, single loaded liposomes and RIF/INH co-loaded liposomes (mean ± standard 
deviation).  
 
 
 
 
 
 
 
 
 
 
 
 
 
p* < 0.05 with respect to RIF 12% sample, p# < 0.05 with respect to INH. 
 
 
 
  
Liposome content 
Z-Average 
(nm)  
PDI  EE %  DL %  
Unloaded  350 ± 29  0.266 ± 0.030  -  -  
RIF 3%  332 ± 33  0.283 ± 0.094  55.1 ± 6.1  1.7 ± 0.3  
RIF 6%  347 ± 18  0.373 ± 0.115  55.3 ± 6.6  3.8 ± 0.1  
RIF 12%  398 ± 15  0.440 ± 0.073  50.6 ± 7.1  5.9 ± 0.9  
INH 15%  340 ± 25  0.124 ± 0.085  52.5 ± 6.2  7.8 ± 0.4  
INH 30%  379 ± 51  0.262 ± 0.060  56.2 ± 2.8  14.9 ± 0.6  
INH 60%  360 ± 8  0.200 ± 0.046  48.2 ± 0.9  22.4 ± 0.2  
Co-loaded  361 ± 18  0.290 ± 0.032  
RIF: 74.2 ± 6.4*  
INH: 71.3 ± 5.1
# 
 
RIF: 7.7 ± 0.7*  
INH: 9.2 ± 0.2
# 
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Table 2. Best fit structural parameters obtained from the analysis of SANS curves of unloaded liposomes 
and for liposomes loaded with RIF and INH at different concentrations (core radius = rc, lipid-drug shell 
span = ts, lipid-drug SLD = ρs, water-drug shell span = tw, water-drug SLD = ρ0, layer number = N).  
  
  
  
  
  
  
  
 
 
 
 
 
*The corresponding PDI values assuming a Gaussian distribution are reported in square brackets. 
When not indicated, the standard deviations are ~ 2% of the fitting parameters values.  
 
  
Fit parameters 
rc 
(nm)* 
ts 
(nm)* 
ρs 
(10
-6
 Å
-2
) 
tw 
(nm)* 
ρ0 
(10
-6
Å
-2
) 
N 
Liposome 
Size  
(nm) 
Unloaded liposomes 170±3.4 [0.3] 5.0 [0.25] 2.38 1.8 [0.2] 6.42 6 418±7 
RIF 3% 170±3.4 [0.3] 4.6 [0.3] 1.38 2.2 [0.2] 6.40 5 404±7 
RIF 6% 180±3.6 [0.4] 4.0 [0.6] 0.17 2.7 [0.3] 6.30 3 390±7 
RIF 12% 184±3.7 [0.4] 4.1 [0.5] 0.13 2.7 [0.4] 6.40 2-3 397±7 
INH 15% 170±3.4 [0.2] 4.8 [0.3] 3.13 2.0 [0.6] 6.42 6 418±7 
INH 30% 170±3.4 [0.2] 4.8 [0.3] 3.13 1.9 [0.6] 6.38 6 417±7 
INH 60% 172±3.4 [0.2] 4.6 [0.3] 3.13 1.6 [0.6] 6.00 5 403±7 
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Table 3. Structural parameters of liposome loaded with both drugs obtained from the analysis of SANS 
curves (core radius = rc, lipid-drug shell span = ts, lipid-drug SLD = ρs, water-drug shell span = tw, water-
drug SLD = ρ0, layer number = N). 
Fit parameters INH 15% + RIF 12% 
rc (nm)* 167±3.3 [0.3] 
ts (nm)* 4.8 [0.3] 
ρs (10
-6
 Å
-2
) 3.06 
tw (nm)* 2.0 [0.6] 
ρ0 (10
-6
 Å
-2
) 6.40 
N 4 
Liposome Size (nm) 384 ± 7 
 
*The corresponding PDI values assuming a Gaussian distribution are reported in square brackets.  
When not indicated, the standard deviations are ~ 2% of the fitting parameters values. 
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Figure Captions  
Figure 1. Multi-lamellar liposome representation showing the hypothesized localization of RIF 
and INH within its structure.  
  
Figure 2. Multi-lamellar model of liposome showing the main parameters determined by SANS. 
The scattering length density SLD of the lipid layers s and the internal water layers 0 depend on 
the material composition; the span of the layers is ts, for the lipid phase and tw for the inter-
lamellar water phase. 
 
Figure 3. In vitro release profiles from liposomes of a) RIF, b) INH.  
 
Figure 4. SANS profiles of unloaded and RIF-loaded liposomes at various RIF concentrations. 
Best fits (solid lines) are superimposed to the experimental points (empty circles). The reduced χ2 
values associated to the best fits are 0.32 (black), 0.12 (red), 0.45 (blue), 0.25 (green). 
  
Figure 5. SANS profiles of empty liposomes and INH-loaded liposomes at various INH 
concentrations. Best fits (solid lines) are superimposed to the experimental points (empty circles). 
The reduced χ2 values associated to the best fits are 0.32 (black), 0.45 (red), 0.23 (green), 0.12 
(blue). 
 
Figure 6. SANS profile of liposomes loaded with both INH and RIF at different relative 
concentrations compared with the scattering curve of empty liposomes (in black). Best fits (solid 
lines) are superimposed to the experimental points (empty circles). The curves have been 
translated to better visualize the differences between the trends. The reduced χ2 values associated 
to the best fits are 0.32 (black) 0.30 (dark cyan). 
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